Concepedia

Minkyung Ko

MK

5

Publications

241

Citations

5

H-Index

2013

Active since

Affiliations

Korea Institute of Science and Technology(Current)

Asan Medical Center

University of Ulsan

Korea University

Ulsan College

Minkyung Ko is an author at Korea Institute of Science and Technology specializing in medicine, crispr, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2022

5

Publications

5

CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy

Hyung‐seung Jin, Minkyung Ko, Dasom Choi et al. · Cancer Immunology Research · 2020 · 82 citations

LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

Eun-Sil Sung, Minkyung Ko, Ju‐young Won et al. · Molecular Therapy · 2022 · 71 citations · Full text

Extracellular pH modulating injectable gel for enhancing immune checkpoint inhibitor therapy

Hyung‐seung Jin, Da-som Choi, Minkyung Ko et al. · Journal of Controlled Release · 2019 · 39 citations · Full text

Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor ligands for the treatment of obesity

Ha Yun Yang, Jinsung Tae, Yong-Wan Seo et al. · European Journal of Medicinal Chemistry · 2013 · 25 citations · Full text

, , +7

Genome wide CRISPR screening reveals a role for sialylation in the tumorigenesis and chemoresistance of acute myeloid leukemia cells

Dong-Hee Lee, Seong-Ho Kang, Dasom Choi et al. · Cancer Letters · 2021 · 24 citations

, , +7

Rows per page

1–5 of 5